Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IOVA
#1113
Iovance Biotherapeutics, Inc. - Common Stock
14.5
0
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.41%
Monthly Change
+57.44%
6 month change
+294.02%
Year Change
+577.57%
Previous Close
14.5
6
Open
14.4
8
Low
14.3
2
High
14.8
0
Markets
US Stock Market
Healthcare
Biotechnology
IOVA
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
146.98 M
157.17 M
224.24 M
279.31 M
327.88 M
411.96 M
452.97 M
Valuation ratios
Enterprise value
6.75 B
2.92 B
1.14 B
2.15 B
2.31 B
961.58 M
5.74 B
Price to earnings ratio
—
-8.56
-2.45
-4.29
-5.78
-2.5
—
Price to sales ratio
—
—
2.45
1.6
0.01
0
0.02
Price to cash flow ratio
—
-0.01
-0
-0.01
-0.01
-0
-0.04
Price to book ratio
—
0
0
0
0
0
0
Enterprise value to EBITDA ratio
—
—
-2.92
-4.79
-6.03
-2.46
-19.96
Profitability ratios
Return on assets %
-0.34
-0.44
-0.6
-0.57
-0.41
-0.43
-0.05
Return on equity %
-0.4
-0.55
-0.79
-0.76
-0.52
-0.56
-0.06
Return on invested capital %
-1 203.92
-817.46
-815.62
-539.42
-327.77
-332.37
-40.34
Gross margin %
—
—
100
-804.54
24.43
34.28
56.1
Operating margin %
—
—
100.47 K
-38.73 K
-240.92
-153.08
-52.26
EBITDA margin %
—
—
98.23 K
-37.76 K
-233.63
-148.19
-48.45
Net margin %
—
—
99.72 K
-37.35 K
-226.84
-148.38
-47.64
Liquidity ratios
Quick ratio
—
—
—
2.7
3.31
2.83
3.82
Current ratio
11.59
5.69
5.24
2.79
3.74
3.2
4.35
Inventory turnover
—
—
—
—
—
0.26
0.06
Asset turnover
—
—
-0
0
0.19
0.29
0.11
Solvency ratios
Debt to assets ratio
—
0
0
0
0
—
—
Debt to equity ratio
—
0
0
0
0
—
—
Long term debt to total assets ratio
—
0
0
0
0
0
—
Long term debt to total equity ratio
—
0
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
-1 485.87
-1 838.24
-1 538.8
-1 217.68
-846.26
-334.74
EBIT per share
—
—
-2 502.09
-1 958.73
-1 363.61
-1 128.76
-370.15
EBITDA per share
—
—
-2 448.62
-1 909.54
-1 322.32
-1 092.76
-349.4
Total debt per share
—
6.52
6.28
4.25
3.45
—
—
Cash per share
—
3 288.07
2 962.75
1 190.26
1 116.96
831.07
661.22
Net current asset value per share
—
3 311.19
3 008.41
1 309.26
1 576.59
1 238.83
1 031.25
Tangible book value per share
—
4 052.38
3 137.27
2 486.33
2 450.71
1 173.26
1 048.78
Working capital per share
—
2 729.72
2 433.97
840.14
1 154.55
851.64
793.91
Book value per share
—
4 052.38
3 137.27
2 486.33
2 450.71
1 954.92
1 634.96
News
Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $18
10 Health Care Stocks Whale Activity In Today’s Session
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Baird Maintains Neutral on Iovance Biotherapeutics, Raises Price Target to $11
Transcript: Iovance Biotherapeutics Q2 2026 Earnings Conference Call
Top 3 Health Care Stocks That May Collapse In Q4
Iovance: Buy Now Before Many Growth Catalysts Kick In (NASDAQ:IOVA)
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
10 Health Care Stocks With Whale Alerts In Today’s Session
Wells Fargo Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $18
Iovance Biotherapeutics Stock Pauses After Hitting New 52-Week High: What's Going On?
IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026